
Jun 17, 2025, 06:57
Maria Gemelli: The Latest Meta-analysis on the Role of ICIs in PD-L1 Negative NSCLC
Maria Gemelli, Medical Oncologist at MultiMedica Group, shared a post on X about a paper she co-authored with colleagues, published in Lung Cancer:
“Now Online!
Happy to share our latest meta-analysis on the role of ICIs in PD-L1 negative NSCLC.
Grateful to all the co-authors.”
Title: Efficacy of immune checkpoint inhibitors (ICIs) in PD-L1 negative non-small cell Lung cancer (NSCLC) – A meta-analysis based on reconstructed individual participant data
Authors: Maria Gemelli, Diego Cortinovis, Giorgia Carola, Laura Moretti, Francesca Piazza, Stefano Calza, Riccardo Ricotta, Salvatore Grisanti, Matteo Rota
You can read the Full Article in Lung Cancer.
More posts featuring Maria Gemelli.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 17, 2025, 06:53
Jun 17, 2025, 06:49
Jun 17, 2025, 06:44
Jun 17, 2025, 06:28
Jun 17, 2025, 06:19